nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0774	0.0889	CbGbCtD
Quinidine—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0694	0.0798	CbGbCtD
Quinidine—ABCC2—Sulfasalazine—ankylosing spondylitis	0.068	0.0781	CbGbCtD
Quinidine—SLCO1A2—Prednisone—ankylosing spondylitis	0.0656	0.0753	CbGbCtD
Quinidine—ABCB11—Dexamethasone—ankylosing spondylitis	0.0645	0.0742	CbGbCtD
Quinidine—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0409	0.047	CbGbCtD
Quinidine—ABCC2—Dexamethasone—ankylosing spondylitis	0.0339	0.039	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0329	0.0378	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—ankylosing spondylitis	0.031	0.0357	CbGbCtD
Quinidine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0292	0.0336	CbGbCtD
Quinidine—SLC22A8—Methotrexate—ankylosing spondylitis	0.0286	0.0329	CbGbCtD
Quinidine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0283	0.0325	CbGbCtD
Quinidine—ABCC2—Methotrexate—ankylosing spondylitis	0.0273	0.0313	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0227	0.026	CbGbCtD
Quinidine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0227	0.026	CbGbCtD
Quinidine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0219	0.0251	CbGbCtD
Quinidine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0216	0.0248	CbGbCtD
Quinidine—ABCB1—Betamethasone—ankylosing spondylitis	0.019	0.0219	CbGbCtD
Quinidine—ABCB1—Prednisolone—ankylosing spondylitis	0.0188	0.0216	CbGbCtD
Quinidine—ABCB1—Prednisone—ankylosing spondylitis	0.0177	0.0204	CbGbCtD
Quinidine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0175	0.0201	CbGbCtD
Quinidine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0163	0.0188	CbGbCtD
Quinidine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0133	0.0153	CbGbCtD
Quinidine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0114	0.0131	CbGbCtD
Quinidine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0114	0.0131	CbGbCtD
Quinidine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0112	0.0129	CbGbCtD
Quinidine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0111	0.0127	CbGbCtD
Quinidine—CYP3A4—Prednisone—ankylosing spondylitis	0.0106	0.0122	CbGbCtD
Quinidine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0104	0.012	CbGbCtD
Quinidine—ABCB1—Methotrexate—ankylosing spondylitis	0.00889	0.0102	CbGbCtD
Quinidine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00663	0.00762	CbGbCtD
Quinidine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000328	0.00252	CcSEcCtD
Quinidine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000328	0.00252	CcSEcCtD
Quinidine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000325	0.00251	CcSEcCtD
Quinidine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000325	0.0025	CcSEcCtD
Quinidine—Ataxia—Methotrexate—ankylosing spondylitis	0.000324	0.0025	CcSEcCtD
Quinidine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000322	0.00248	CcSEcCtD
Quinidine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000318	0.00245	CcSEcCtD
Quinidine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000316	0.00243	CcSEcCtD
Quinidine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000316	0.00243	CcSEcCtD
Quinidine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000316	0.00243	CcSEcCtD
Quinidine—Erythema—Triamcinolone—ankylosing spondylitis	0.000314	0.00242	CcSEcCtD
Quinidine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000314	0.00242	CcSEcCtD
Quinidine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000314	0.00242	CcSEcCtD
Quinidine—Angioedema—Prednisolone—ankylosing spondylitis	0.000312	0.00241	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—ankylosing spondylitis	0.000311	0.0024	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00031	0.00239	CcSEcCtD
Quinidine—Vertigo—Prednisolone—ankylosing spondylitis	0.000307	0.00236	CcSEcCtD
Quinidine—Syncope—Prednisolone—ankylosing spondylitis	0.000306	0.00236	CcSEcCtD
Quinidine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000306	0.00236	CcSEcCtD
Quinidine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000306	0.00236	CcSEcCtD
Quinidine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.0003	0.00231	CcSEcCtD
Quinidine—Asthma—Methotrexate—ankylosing spondylitis	0.000298	0.00229	CcSEcCtD
Quinidine—Convulsion—Prednisolone—ankylosing spondylitis	0.000296	0.00228	CcSEcCtD
Quinidine—Bradycardia—Prednisone—ankylosing spondylitis	0.00029	0.00224	CcSEcCtD
Quinidine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000287	0.00221	CcSEcCtD
Quinidine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000287	0.00221	CcSEcCtD
Quinidine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000287	0.00221	CcSEcCtD
Quinidine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000285	0.0022	CcSEcCtD
Quinidine—Erythema—Dexamethasone—ankylosing spondylitis	0.000285	0.0022	CcSEcCtD
Quinidine—Erythema—Betamethasone—ankylosing spondylitis	0.000285	0.0022	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000283	0.00218	CcSEcCtD
Quinidine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000282	0.00217	CcSEcCtD
Quinidine—Syncope—Triamcinolone—ankylosing spondylitis	0.000282	0.00217	CcSEcCtD
Quinidine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000282	0.00217	CcSEcCtD
Quinidine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000281	0.00217	CcSEcCtD
Quinidine—Oedema—Prednisolone—ankylosing spondylitis	0.000279	0.00215	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000279	0.00215	CcSEcCtD
Quinidine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000276	0.00213	CcSEcCtD
Quinidine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000276	0.00212	CcSEcCtD
Quinidine—Shock—Prednisolone—ankylosing spondylitis	0.000274	0.00211	CcSEcCtD
Quinidine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000272	0.0021	CcSEcCtD
Quinidine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000272	0.0021	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000272	0.00209	CcSEcCtD
Quinidine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000272	0.00209	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00027	0.00208	CcSEcCtD
Quinidine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000268	0.00206	CcSEcCtD
Quinidine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000267	0.00206	CcSEcCtD
Quinidine—Eye disorder—Prednisone—ankylosing spondylitis	0.000267	0.00205	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000265	0.00204	CcSEcCtD
Quinidine—Flushing—Prednisone—ankylosing spondylitis	0.000265	0.00204	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000263	0.00203	CcSEcCtD
Quinidine—Renal failure—Methotrexate—ankylosing spondylitis	0.000261	0.00201	CcSEcCtD
Quinidine—Angioedema—Betamethasone—ankylosing spondylitis	0.000261	0.00201	CcSEcCtD
Quinidine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000261	0.00201	CcSEcCtD
Quinidine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000258	0.00199	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000258	0.00198	CcSEcCtD
Quinidine—Oedema—Triamcinolone—ankylosing spondylitis	0.000257	0.00198	CcSEcCtD
Quinidine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000256	0.00197	CcSEcCtD
Quinidine—Vertigo—Betamethasone—ankylosing spondylitis	0.000256	0.00197	CcSEcCtD
Quinidine—Syncope—Betamethasone—ankylosing spondylitis	0.000256	0.00197	CcSEcCtD
Quinidine—Syncope—Dexamethasone—ankylosing spondylitis	0.000256	0.00197	CcSEcCtD
Quinidine—Sweating—Methotrexate—ankylosing spondylitis	0.000255	0.00196	CcSEcCtD
Quinidine—Shock—Triamcinolone—ankylosing spondylitis	0.000252	0.00194	CcSEcCtD
Quinidine—Shock—Methylprednisolone—ankylosing spondylitis	0.000252	0.00194	CcSEcCtD
Quinidine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000251	0.00193	CcSEcCtD
Quinidine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000251	0.00193	CcSEcCtD
Quinidine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000251	0.00193	CcSEcCtD
Quinidine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00025	0.00193	CcSEcCtD
Quinidine—Mental disorder—Prednisone—ankylosing spondylitis	0.00025	0.00193	CcSEcCtD
Quinidine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00025	0.00192	CcSEcCtD
Quinidine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000249	0.00191	CcSEcCtD
Quinidine—Malnutrition—Prednisone—ankylosing spondylitis	0.000248	0.00191	CcSEcCtD
Quinidine—Erythema—Prednisone—ankylosing spondylitis	0.000248	0.00191	CcSEcCtD
Quinidine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000248	0.00191	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000248	0.00191	CcSEcCtD
Quinidine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000247	0.00191	CcSEcCtD
Quinidine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000247	0.0019	CcSEcCtD
Quinidine—Convulsion—Betamethasone—ankylosing spondylitis	0.000247	0.0019	CcSEcCtD
Quinidine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000243	0.00187	CcSEcCtD
Quinidine—Myalgia—Betamethasone—ankylosing spondylitis	0.000243	0.00187	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00024	0.00185	CcSEcCtD
Quinidine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000239	0.00184	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000238	0.00184	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000238	0.00184	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000235	0.00181	CcSEcCtD
Quinidine—Vision blurred—Prednisone—ankylosing spondylitis	0.000234	0.0018	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000234	0.0018	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000234	0.0018	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000233	0.0018	CcSEcCtD
Quinidine—Oedema—Betamethasone—ankylosing spondylitis	0.000233	0.00179	CcSEcCtD
Quinidine—Oedema—Dexamethasone—ankylosing spondylitis	0.000233	0.00179	CcSEcCtD
Quinidine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00023	0.00177	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00023	0.00177	CcSEcCtD
Quinidine—Shock—Dexamethasone—ankylosing spondylitis	0.000229	0.00176	CcSEcCtD
Quinidine—Shock—Betamethasone—ankylosing spondylitis	0.000229	0.00176	CcSEcCtD
Quinidine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000229	0.00176	CcSEcCtD
Quinidine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000228	0.00176	CcSEcCtD
Quinidine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000228	0.00176	CcSEcCtD
Quinidine—Agitation—Prednisone—ankylosing spondylitis	0.000228	0.00176	CcSEcCtD
Quinidine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000228	0.00176	CcSEcCtD
Quinidine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000228	0.00176	CcSEcCtD
Quinidine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000227	0.00175	CcSEcCtD
Quinidine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000227	0.00175	CcSEcCtD
Quinidine—Angioedema—Prednisone—ankylosing spondylitis	0.000227	0.00175	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000225	0.00174	CcSEcCtD
Quinidine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000225	0.00173	CcSEcCtD
Quinidine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000225	0.00173	CcSEcCtD
Quinidine—Vertigo—Prednisone—ankylosing spondylitis	0.000223	0.00172	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000223	0.00172	CcSEcCtD
Quinidine—Syncope—Prednisone—ankylosing spondylitis	0.000223	0.00172	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000222	0.00171	CcSEcCtD
Quinidine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000222	0.00171	CcSEcCtD
Quinidine—Anorexia—Betamethasone—ankylosing spondylitis	0.000222	0.00171	CcSEcCtD
Quinidine—Urticaria—Prednisolone—ankylosing spondylitis	0.000222	0.00171	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000221	0.0017	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000218	0.00168	CcSEcCtD
Quinidine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000217	0.00168	CcSEcCtD
Quinidine—Hypotension—Betamethasone—ankylosing spondylitis	0.000217	0.00168	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000215	0.00166	CcSEcCtD
Quinidine—Convulsion—Prednisone—ankylosing spondylitis	0.000215	0.00166	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000215	0.00166	CcSEcCtD
Quinidine—Chills—Methotrexate—ankylosing spondylitis	0.000214	0.00165	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000212	0.00163	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000212	0.00163	CcSEcCtD
Quinidine—Myalgia—Prednisone—ankylosing spondylitis	0.000211	0.00163	CcSEcCtD
Quinidine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000211	0.00163	CcSEcCtD
Quinidine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000211	0.00162	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00021	0.00162	CcSEcCtD
Quinidine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000209	0.00161	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000209	0.00161	CcSEcCtD
Quinidine—Erythema—Methotrexate—ankylosing spondylitis	0.000208	0.0016	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000208	0.0016	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000206	0.00158	CcSEcCtD
Quinidine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000204	0.00157	CcSEcCtD
Quinidine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000203	0.00157	CcSEcCtD
Quinidine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000203	0.00156	CcSEcCtD
Quinidine—Oedema—Prednisone—ankylosing spondylitis	0.000203	0.00156	CcSEcCtD
Quinidine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000202	0.00156	CcSEcCtD
Quinidine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000202	0.00156	CcSEcCtD
Quinidine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000202	0.00156	CcSEcCtD
Quinidine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000201	0.00155	CcSEcCtD
Quinidine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000201	0.00155	CcSEcCtD
Quinidine—Shock—Prednisone—ankylosing spondylitis	0.000199	0.00154	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000199	0.00153	CcSEcCtD
Quinidine—Tachycardia—Prednisone—ankylosing spondylitis	0.000198	0.00152	CcSEcCtD
Quinidine—Skin disorder—Prednisone—ankylosing spondylitis	0.000197	0.00152	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000196	0.00151	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000196	0.00151	CcSEcCtD
Quinidine—Anorexia—Prednisone—ankylosing spondylitis	0.000193	0.00149	CcSEcCtD
Quinidine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000192	0.00148	CcSEcCtD
Quinidine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000192	0.00148	CcSEcCtD
Quinidine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00019	0.00147	CcSEcCtD
Quinidine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00019	0.00147	CcSEcCtD
Quinidine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000189	0.00146	CcSEcCtD
Quinidine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000189	0.00145	CcSEcCtD
Quinidine—Vertigo—Methotrexate—ankylosing spondylitis	0.000186	0.00144	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000186	0.00143	CcSEcCtD
Quinidine—Urticaria—Betamethasone—ankylosing spondylitis	0.000185	0.00142	CcSEcCtD
Quinidine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000185	0.00142	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000185	0.00142	CcSEcCtD
Quinidine—Dizziness—Prednisolone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000184	0.00142	CcSEcCtD
Quinidine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000184	0.00141	CcSEcCtD
Quinidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000181	0.0014	CcSEcCtD
Quinidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000181	0.00139	CcSEcCtD
Quinidine—Convulsion—Methotrexate—ankylosing spondylitis	0.00018	0.00139	CcSEcCtD
Quinidine—Chest pain—Methotrexate—ankylosing spondylitis	0.000177	0.00136	CcSEcCtD
Quinidine—Myalgia—Methotrexate—ankylosing spondylitis	0.000177	0.00136	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000176	0.00136	CcSEcCtD
Quinidine—Rash—Prednisolone—ankylosing spondylitis	0.000176	0.00135	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000176	0.00135	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000175	0.00135	CcSEcCtD
Quinidine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000175	0.00135	CcSEcCtD
Quinidine—Headache—Prednisolone—ankylosing spondylitis	0.000175	0.00135	CcSEcCtD
Quinidine—Confusional state—Methotrexate—ankylosing spondylitis	0.000171	0.00132	CcSEcCtD
Quinidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00017	0.00131	CcSEcCtD
Quinidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000169	0.0013	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000167	0.00129	CcSEcCtD
Quinidine—Asthenia—Betamethasone—ankylosing spondylitis	0.000167	0.00129	CcSEcCtD
Quinidine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000167	0.00129	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000166	0.00128	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000166	0.00128	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000166	0.00128	CcSEcCtD
Quinidine—Nausea—Prednisolone—ankylosing spondylitis	0.000166	0.00128	CcSEcCtD
Quinidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000165	0.00127	CcSEcCtD
Quinidine—Pruritus—Betamethasone—ankylosing spondylitis	0.000165	0.00127	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000165	0.00127	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000164	0.00126	CcSEcCtD
Quinidine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000163	0.00126	CcSEcCtD
Quinidine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000163	0.00125	CcSEcCtD
Quinidine—Rash—Triamcinolone—ankylosing spondylitis	0.000162	0.00125	CcSEcCtD
Quinidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000162	0.00124	CcSEcCtD
Quinidine—Anorexia—Methotrexate—ankylosing spondylitis	0.000161	0.00124	CcSEcCtD
Quinidine—Rash—Methylprednisolone—ankylosing spondylitis	0.000161	0.00124	CcSEcCtD
Quinidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000161	0.00124	CcSEcCtD
Quinidine—Urticaria—Prednisone—ankylosing spondylitis	0.000161	0.00124	CcSEcCtD
Quinidine—Headache—Triamcinolone—ankylosing spondylitis	0.000161	0.00124	CcSEcCtD
Quinidine—Headache—Methylprednisolone—ankylosing spondylitis	0.00016	0.00123	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00016	0.00123	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00016	0.00123	CcSEcCtD
Quinidine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000159	0.00123	CcSEcCtD
Quinidine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000159	0.00123	CcSEcCtD
Quinidine—Hypotension—Methotrexate—ankylosing spondylitis	0.000158	0.00122	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000154	0.00119	CcSEcCtD
Quinidine—Dizziness—Betamethasone—ankylosing spondylitis	0.000154	0.00119	CcSEcCtD
Quinidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000154	0.00119	CcSEcCtD
Quinidine—Nausea—Triamcinolone—ankylosing spondylitis	0.000152	0.00117	CcSEcCtD
Quinidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000152	0.00117	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000151	0.00116	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000149	0.00115	CcSEcCtD
Quinidine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000148	0.00114	CcSEcCtD
Quinidine—Vomiting—Betamethasone—ankylosing spondylitis	0.000148	0.00114	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000147	0.00113	CcSEcCtD
Quinidine—Rash—Betamethasone—ankylosing spondylitis	0.000147	0.00113	CcSEcCtD
Quinidine—Rash—Dexamethasone—ankylosing spondylitis	0.000147	0.00113	CcSEcCtD
Quinidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000147	0.00113	CcSEcCtD
Quinidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000147	0.00113	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000146	0.00113	CcSEcCtD
Quinidine—Headache—Betamethasone—ankylosing spondylitis	0.000146	0.00112	CcSEcCtD
Quinidine—Headache—Dexamethasone—ankylosing spondylitis	0.000146	0.00112	CcSEcCtD
Quinidine—Asthenia—Prednisone—ankylosing spondylitis	0.000145	0.00112	CcSEcCtD
Quinidine—Pruritus—Prednisone—ankylosing spondylitis	0.000143	0.0011	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00014	0.00108	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000139	0.00107	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000139	0.00107	CcSEcCtD
Quinidine—Nausea—Betamethasone—ankylosing spondylitis	0.000138	0.00106	CcSEcCtD
Quinidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000138	0.00106	CcSEcCtD
Quinidine—Urticaria—Methotrexate—ankylosing spondylitis	0.000135	0.00104	CcSEcCtD
Quinidine—Dizziness—Prednisone—ankylosing spondylitis	0.000134	0.00103	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000134	0.00103	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000134	0.00103	CcSEcCtD
Quinidine—Vomiting—Prednisone—ankylosing spondylitis	0.000129	0.000993	CcSEcCtD
Quinidine—Rash—Prednisone—ankylosing spondylitis	0.000128	0.000984	CcSEcCtD
Quinidine—Dermatitis—Prednisone—ankylosing spondylitis	0.000128	0.000983	CcSEcCtD
Quinidine—Headache—Prednisone—ankylosing spondylitis	0.000127	0.000978	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000125	0.000961	CcSEcCtD
Quinidine—Asthenia—Methotrexate—ankylosing spondylitis	0.000122	0.000936	CcSEcCtD
Quinidine—Nausea—Prednisone—ankylosing spondylitis	0.00012	0.000927	CcSEcCtD
Quinidine—Pruritus—Methotrexate—ankylosing spondylitis	0.00012	0.000923	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000116	0.000893	CcSEcCtD
Quinidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000112	0.000863	CcSEcCtD
Quinidine—Vomiting—Methotrexate—ankylosing spondylitis	0.000108	0.00083	CcSEcCtD
Quinidine—Rash—Methotrexate—ankylosing spondylitis	0.000107	0.000823	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000107	0.000822	CcSEcCtD
Quinidine—Headache—Methotrexate—ankylosing spondylitis	0.000106	0.000817	CcSEcCtD
Quinidine—Nausea—Methotrexate—ankylosing spondylitis	0.000101	0.000775	CcSEcCtD
